The LRG Welcomes Dr. Neeta Somaiah to Medical Advisory Board
The Life Raft Group welcomes our newest Medical Advisory Board (MAB) member Dr. Neeta Somaiah of The University of Texas MD Anderson Cancer Center.
The Life Raft Group welcomes our newest Medical Advisory Board (MAB) member Dr. Neeta Somaiah of The University of Texas MD Anderson Cancer Center.
US GIST Mentor Director, Santy DiSabatino, shares what having a Mentor means to the newly diagnosed and what being a GIST Mentor means to him and he makes an appeal for more volunteers to mentor LRG patients and caregivers.
In this summary, we continue highlighting recent clinical trials that are still recruiting in the U.S. which investigate potential treatments for GIST patients.
The Life Raft Group is celebrating our 20th anniversary as a nonprofit in 2022. For twenty years, our organization has been serving as a life raft for others navigating their GIST journeys.
A recent paper published in Cancers by CTOS and SPAEN highlights major findings and proposes potential future steps in global sarcoma care.
A new article published this month is presented by the University of Texas MD Anderson Cancer Center Department of Sarcoma Medical Oncology. Understanding Sarcoma Drug Resistance One Cell at a Time discusses that the focus in GIST research is moving from the current focus on just histology, proteomics, and tumor genetics enabled by tumor samples, cell lines and mouse models which are limited in rare cancers like SDH-deficient GIST.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Paul Nadolny shares his story.
Chelsea Madia has been an extraordinary volunteer and fundraiser for the LRG! We appreciate all she has done.
Jimit Mody shares his GIST journey and how a positive attitude and determination keeps him going.
December 2021 - In this summary, we have highlighted recent clinical trials that are still recruiting in the U.S. which investigate potential treatments for GIST patients.